Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRIM24 | O15164 | 1/20 | 0.43 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.43 |
| ▸ | ESR1 | P03372 | 1/20 | 0.42 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.41 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.41 |
| ▸ | KMO | O15229 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.38 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.38 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.37 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.36 |
| ▸ | FEN1 | P39748 | 1/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.35 |
| ▸ | BAD | Q92934 | 1/20 | 0.35 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4827188 | 0.98 | TRIM24 (0.42) | TRIM24TRIM33ESR1CYP19A1CYP11B2 | |
| SCHEMBL2086861 | 0.89 | CYP19A1 (0.44) | TRIM24TRIM33ESR1CYP19A1CYP11B2 | |
| SCHEMBL4820461 | 0.86 | CYP19A1 (0.44) | ESR1CYP19A1CYP11B2TP53PTGS2 | |
| SCHEMBL13697102 | 0.86 | CYP19A1 (0.39) | TRIM24TRIM33ESR1CYP19A1CYP11B2 | |
| SCHEMBL2322371 | 0.85 | ESR1 (0.58) | ESR1CYP19A1CYP11B2PTGS2ALDH1A1 | |
| SCHEMBL4826058 | 0.85 | CYP19A1 (0.52) | ESR1CYP19A1CYP11B2TP53PTGS2 | |
| SCHEMBL2085977 | 0.84 | CYP19A1 (0.45) | ESR1CYP19A1CYP11B2KMOTP53 | |
| SCHEMBL76484 | 0.83 | CYP19A1 (0.53) | ESR1CYP19A1CYP11B2TP53PTGS2 | |
| SCHEMBL29416717 | 0.83 | CYP19A1 (0.53) | ESR1CYP19A1CYP11B2TP53PTGS2 | |
| SCHEMBL4828686 | 0.83 | ESR1 (0.41) | TRIM24TRIM33ESR1CYP19A1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080193799-A1 | Organic electroluminescence device | IDEMITSU KOSAN CO., LTD. (JP) | 2008-08-14 | — | — | US | disclosed |
| US-7361796-B2 | Orangic electroluminescence device | IDEMITSU KOSAN CO., LTD. (JP) | 2008-04-22 | — | — | US | disclosed |
| US-7053255-B2 | Substituted diphenylanthracene compounds for organic electroluminescence devices | IDEMITSU KOSAN CO., LTD. (JP) | 2006-05-30 | — | — | US | disclosed |
| US-20060083947-A1 | Organic electroluminescence device | IDEMITSU KOSAN CO., LTD. (JP) | 2006-04-20 | — | — | US | disclosed |
| US-20040214035-A1 | Organic electroluminescence device | IDEMITSU KOSAN CO., LTD. | 2004-10-28 | — | — | US | disclosed |
| EP-1333018-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | IDEMITSU KOSAN CO., LTD. (JP) | 2003-08-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080193799-A1 | Organic electroluminescence device | EED, KCNH2, DCX | TRIM24 2408/4885TRIM33 2991/4885ESR1 333/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.